270 studies found for:    "Expanded Access" [STUDY-TYPES]
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 No longer available A Treatment Investigational New Drug (tIND) Program of Tegaserod in Women With Irritable Bowel Syndrome With Constipation or With Chronic Idiopathic Constipation
Conditions: Irritable Bowel Syndrome With Constipation;   Chronic Idiopathic Constipation
Intervention: Drug: Tegaserod
2 No longer available Compassionate Use of Defibrotide for Patients With Veno-occlusive Disease of the Liver
Condition: Hepatic Veno-occlusive Disease
Intervention: Drug: Defibrotide
3 Unknown  HIV-discordant Couple Intrauterine Insemination
Conditions: Infertility;   HIV Infections
Interventions: Other: Sperm washing and testing for HIV contamination;   Procedure: Intrauterine Insemination
4 No longer available Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) With 3, 4 DAP
Condition: Lambert Eaton Myasthenic Syndrome (LEMS)
Intervention: Drug: 3,4-diaminopyridine
5 No longer available Prochymal® Expanded Access for Adults Who Have Failed Steroid Treatment for Acute GVHD
Condition: Graft-Versus-Host Disease
Intervention: Drug: Prochymal®
6 Available Use Massive Parallel Sequencing and Exome Capture Technology to Sequence the Exome of Fanconi Anemia Children and Their Patents
Conditions: Fanconi Anemia;   Autosomal or Sex Linked Recessive Genetic Disease;   Bone Marrow Hematopoiesis Failure, Multiple Congenital Abnormalities, and Susceptibility to Neoplastic Diseases.;   Hematopoiesis Maintainance.
Interventions: Genetic: human whole exome;   Genetic: whole genomic
7 No longer available An Open Label Safety Study of Tipranavir Co-administered With Low-dose Ritonavir in Patients With Advanced HIV-1 Infection and Limited Treatment Options.
Condition: HIV Infections
Intervention: Drug: Tipranavir
8 Available Compassionate Use of Omegaven for Pediatric Patients With Parenteral Nutrition Associated Liver Disease
Conditions: Cholestasis;   Short Bowel Syndrome
Intervention: Drug: Omegaven
9 Available 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome (LEMS) and Congenital Myasthenia (CM)
Conditions: Lambert-Eaton Myasthenic Syndrome (LEMS);   Congenital Myasthenia (CM)
Intervention: Drug: 3,4-diaminopyridine
10 Available Bosutinib Treatment Extension Study Only For Subjects With Chronic Myeloid Leukemia (CML) Who Have Previously Participated In Bosutinib Studies B1871006 Or B1871008
Condition: Chronic Myeloid Leukemia
Intervention: Drug: bosutinib
11 Available An Extended Access Program for Perampanel
Condition: Partial Onset Seizures
Intervention: Drug: Perampanel
12 No longer available B-Lymphocyte Immunotherapy in Islet Transplantation for Initial Islet Graft Failure
Condition: Type 1 Diabetes Mellitus
Interventions: Biological: Allogeneic Pancreatic Islet Cells;   Drug: Sirolimus;   Biological: Basiliximab;   Drug: Tacrolimus;   Drug: Antibacterial, Antifungal, and Antiviral Prophylaxis;   Drug: Trimethoprim/sulfamethoxazole;   Drug: Clotrimazole;   Drug: Valganciclovir;   Drug: Heparin;   Drug: Enoxaparin;   Drug: Pentoxifylline;   Drug: Aspirin
13 Available Use Of 3,4-Diaminopyridine (3,4-DAP) In The Treatment Of Lambert Eaton Myasthenic Syndrome
Condition: Lambert-Eaton Myasthenic Syndrome
Intervention: Drug: 3,4 DAP
14 No longer available Expanded Access Trial of Plant Expressed Recombinant Glucocerebrosidase (prGCD) in Patients With Gaucher Disease
Condition: Gaucher Disease
Intervention: Drug: Plant cell expressed recombinant glucocerebrosidase (prGCD)
15 No longer available Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection
Condition: HIV Infections
Intervention: Drug: Tipranavir
16 Available Compassionate Use of Stanate (TM) [Stannsoporfin]
Conditions: Neonatal Jaundice;   Hyperbilirubinemia
Intervention: Drug: Stanate (TM) [stannsoporfin, tin-mesoporphyrin]
17 Approved for marketing Treatment Protocol of Velaglucerase Alfa for Patients With Type 1 Gaucher Disease
Condition: Gaucher Disease, Type 1
Intervention: Drug: velaglucerase alfa
18 No longer available An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection: Canada
Condition: HIV Infection
Intervention: Drug: Efavirenz
19 Available Humanitarian Use of AVANTA Orthopaedics Proximal Interphalangeal Joint
Condition: Arthroplasty of the PIP Joint
Intervention: Device: SR™ PIP
20 No longer available Defibrotide Compassionate Use for Patients With Life Threatening Veno-Occlusive Disease of the Liver
Condition: Liver Diseases
Intervention: Drug: Defibrotide

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years